{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:25:26Z","timestamp":1794565526260,"version":"4.9.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012533","name":"Minia University","doi-asserted-by":"publisher","award":["230302"],"award-info":[{"award-number":["230302"]}],"id":[{"id":"10.13039\/501100012533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpet.2026.103817","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:15:04Z","timestamp":1769213704000},"page":"103817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Empagliflozin mitigates doxorubicin-induced nephrotoxicity by modulating sirtuin 1, nuclear factor-\u03baB\/tumor necrosis factor-\u03b1, and cleaved caspase-3 pathways without compromising its cytotoxic efficacy"],"prefix":"10.1016","volume":"393","author":[{"given":"Amna G.","family":"Tawfik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-2344","authenticated-orcid":false,"given":"Heba A.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9732-6550","authenticated-orcid":false,"given":"Esraa M.","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6907-4441","authenticated-orcid":false,"given":"Gehan H.","family":"Heeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpet.2026.103817_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113373","article-title":"Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents","volume":"144","author":"Lu","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103817_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ijo.2016.3558","article-title":"Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines","volume":"49","author":"Pilco-Ferreto","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jpet.2026.103817_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111308","article-title":"Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation","volume":"137","author":"Wu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2026.103817_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101205","article-title":"Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming","volume":"93","author":"Mattioli","year":"2023","journal-title":"Mol Aspects Med"},{"issue":"3","key":"10.1016\/j.jpet.2026.103817_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.15171\/jnp.2017.41","article-title":"Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review","volume":"6","author":"Heidari-Soreshjani","year":"2017","journal-title":"J Nephropathol"},{"issue":"3","key":"10.1016\/j.jpet.2026.103817_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archinte.1977.03630150079022","article-title":"Doxorubicin hydrochloride-associated renal failure","volume":"137","author":"Burke","year":"1977","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jpet.2026.103817_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/tox.22075","article-title":"Dual effects of quercetin in doxorubicin-induced nephrotoxicity in rats and its modulation of the cytotoxic activity of doxorubicin on human carcinoma cells","volume":"31","author":"Heeba","year":"2016","journal-title":"Environ Toxicol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jpet.2026.103817_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2024.105159","article-title":"Esculetin improves inflammation of the kidney via gene expression against doxorubicin-induced nephrotoxicity in rats: in vivo and in silico studies","volume":"62","author":"Kara\u011fa\u00e7","year":"2024","journal-title":"Food Biosci"},{"issue":"23","key":"10.1016\/j.jpet.2026.103817_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314570","article-title":"Adrenomedullin mitigates doxorubicin-induced nephrotoxicity in rats: role of oxidative stress, inflammation, apoptosis, and pyroptosis","volume":"23","author":"Abd-Ellatif","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"Pt 1","key":"10.1016\/j.jpet.2026.103817_bib12","article-title":"Esculetin attenuates doxorubicin-induced cardiac toxicity: evidence from gene expression, enzyme activity, and molecular docking analyses","volume":"120","author":"Demir","year":"2025","journal-title":"Comput Biol Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.103817_bib13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/cbin.70086","article-title":"Esculetin attenuates doxorubicin-induced cardiotoxicity via modulation of apoptotic and mitochondrial gene expression networks","volume":"49","author":"Demir","year":"2025","journal-title":"Cell Biol Int"},{"issue":"9","key":"10.1016\/j.jpet.2026.103817_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21940","article-title":"Alpha lipoic acid prevents doxorubicin-induced nephrotoxicity by mitigation of oxidative stress, inflammation, and apoptosis in rats","volume":"31","author":"El-Sayed","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jpet.2026.103817_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108777","article-title":"Nicorandil combats doxorubicin-induced nephrotoxicity via amendment of TLR4\/P38 MAPK\/NF\u03ba-B signaling pathway","volume":"311","author":"Khames","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jpet.2026.103817_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1353029","article-title":"Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1\/Nrf2\/NF-\u03baB\/TNF-\u03b1 signaling pathways","volume":"15","author":"Botros","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.103817_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103907","article-title":"Protective effect of empagliflozin on gentamicin-induced acute renal injury via regulation of SIRT1\/NF-\u03baB signaling pathway","volume":"94","author":"Botros","year":"2022","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jpet.2026.103817_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102330","article-title":"Modulation of the sirtuin-1 signaling pathway in doxorubicin-induced nephrotoxicity (synergistic amelioration by resveratrol and pirfenidone)","volume":"87","author":"Manawy","year":"2024","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.jpet.2026.103817_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.32725\/jab.2019.003","article-title":"Pre-treatment with empagliflozin ameliorates cisplatin induced acute kidney injury by suppressing apoptosis","volume":"17","author":"Abd Elmaaboud","year":"2019","journal-title":"J Appl Biomed"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s43094-024-00669-3","article-title":"Empagliflozin mitigates methotrexate-induced nephrotoxicity in male albino rats: insights on the crosstalk of AMPK\/Nrf2 signaling pathway","volume":"10","author":"Mishriki","year":"2024","journal-title":"Fut J Pharm Sci"},{"key":"10.1016\/j.jpet.2026.103817_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175531","article-title":"Empagliflozin ameliorates cardiac dysfunction in heart failure mice via regulating mitochondrial dynamics","volume":"942","author":"Lyu","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.103817_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCULATIONAHA.120.051675","article-title":"Effect of dapagliflozin on clinical outcomes in patients with chronic kidney disease, with and without cardiovascular disease","volume":"143","author":"McMurray","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jpet.2026.103817_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(21)00242-4","article-title":"Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Heerspink","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.jpet.2026.103817_bib25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.2857","article-title":"Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from the EMPEROR-preserved trial","volume":"25","author":"Sharma","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12933-021-01396-2","article-title":"Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study","volume":"20","author":"Lin","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.jpet.2026.103817_bib27","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.sjbs.2021.04.030","article-title":"Protective effect of diosmin against doxorubicin-induced nephrotoxicity","volume":"28","author":"Ali","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.jpet.2026.103817_bib28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.biopha.2018.09.171","article-title":"Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats","volume":"108","author":"Alt\u0131nkaynak","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.jpet.2026.103817_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13901","article-title":"Nephroprotective activity of Vetiveria zizanioides (L.) Nash supplement in doxorubicin-induced nephrotoxicity model of Wistar rats","volume":"45","author":"Amarasiri","year":"2021","journal-title":"J Food Biochem"},{"key":"10.1016\/j.jpet.2026.103817_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1197061","article-title":"Empagliflozin enhances autophagy, mitochondrial biogenesis, and antioxidant defense and ameliorates renal ischemia\/reperfusion in nondiabetic rats","volume":"2022","author":"Ala","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jpet.2026.103817_bib31","article-title":"Allium vineale methanol extract attenuated oxidative stress and inflammation induced by doxorubicin in Sprague Dawley Rats","volume":"16","author":"Akinloye","year":"2022","journal-title":"Sci Afr"},{"key":"10.1016\/j.jpet.2026.103817_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.905828","article-title":"Combination of Panax ginseng C. A. Mey and febuxostat boasted cardioprotective effects against doxorubicin-induced acute cardiotoxicity in rats","volume":"13","author":"Al-Kuraishy","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40360-025-00932-0","article-title":"Protective effects of Alamandine against doxorubicin-induced liver injury in rats","volume":"26","author":"Soltani Hekmat","year":"2025","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103817_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.59566\/IJBS.2013.9082","article-title":"Ameliorative potentials of ginger (Z. officinale Roscoe) on relative organ weights in streptozotocin induced diabetic rats","volume":"9","author":"Eleazu","year":"2013","journal-title":"Int J Biomed Sci"},{"issue":"1940","key":"10.1016\/j.jpet.2026.103817_bib35","first-page":"796","article-title":"Determination of creatinine in serum","volume":"89","author":"Schirmeister","year":"1964","journal-title":"Dtsch Med Wschr"},{"issue":"2","key":"10.1016\/j.jpet.2026.103817_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jcp.13.2.156","article-title":"A rapid and precise method for the determination of urea","volume":"13","author":"Fawcett","year":"1960","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jpet.2026.103817_bib37","series-title":"Theory and Practice of Histological Techniques","first-page":"173","author":"Suvarna","year":"2013"},{"issue":"8","key":"10.1016\/j.jpet.2026.103817_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23798","article-title":"The hepatoprotective potential of tannic acid against doxorubicin-induced hepatotoxicity: insights into its antioxidative, anti-inflammatory, and antiapoptotic mechanisms","volume":"38","author":"\u00d6zturk","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jpet.2026.103817_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2026.103817_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0027-5107(85)90216-7","article-title":"Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB\/c mice","volume":"148","author":"Marklund","year":"1985","journal-title":"Mutat Res"},{"key":"10.1016\/j.jpet.2026.103817_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110153","article-title":"Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L","volume":"127","author":"Laskar","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12906-019-2505-9","article-title":"Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics","volume":"19","author":"Nguyen","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jpet.2026.103817_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.acc.2014.11.007","article-title":"Cystatin C: a kidney function biomarker","volume":"68","author":"Onopiuk","year":"2015","journal-title":"Adv Clin Chem"},{"issue":"5","key":"10.1016\/j.jpet.2026.103817_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00210-019-01619-0","article-title":"\u03b2-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+\/AMPK\/NF-kB in mice","volume":"392","author":"Sanajou","year":"2019","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00210-019-01719-x","article-title":"Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats","volume":"393","author":"Abdelrahman","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jpet.2026.103817_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.toxrep.2023.11.005","article-title":"Nephroprotective effects of diminazene on doxorubicin-induced acute kidney injury in rats","volume":"11","author":"Suleimani","year":"2023","journal-title":"Toxicol Rep"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12291-018-0790-6","article-title":"Empagliflozin attenuates renal and urinary markers of tubular epithelial cell injury in streptozotocin-induced diabetic rats","volume":"35","author":"Ashrafi Jigheh","year":"2020","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.jpet.2026.103817_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109088","article-title":"Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by I\u03baK\/I\u03baB\/NF-\u03baB pathway","volume":"117","author":"Zhu","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxlet.2009.01.025","article-title":"Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities","volume":"187","author":"Hou","year":"2009","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/j.jpet.2026.103817_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3004","article-title":"Assessment of hypolipidemic and anti-inflammatory properties of walnut (Juglans regia) seed coat extract and modulates some metabolic enzymes activity in triton WR-1339-induced hyperlipidemia in rat kidney, liver, and heart","volume":"36","author":"Palab\u0131y\u0131k","year":"2023","journal-title":"J Mol Recognit"},{"issue":"8","key":"10.1016\/j.jpet.2026.103817_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70714","article-title":"Phenolic compounds in exercise physiology: dual role in oxidative stress and recovery adaptation","volume":"13","author":"\u00d6zdemir","year":"2025","journal-title":"Food Sci Nutr"},{"issue":"6","key":"10.1016\/j.jpet.2026.103817_bib53","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/bab.2633","article-title":"Effect of tannic acid on doxorubicin-induced cellular stress: expression levels of heat shock genes in rat spleen","volume":"71","author":"Kizir","year":"2024","journal-title":"Biotechnol Appl Biochem"},{"issue":"10","key":"10.1016\/j.jpet.2026.103817_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23861","article-title":"The protective effects of esculetin against doxorubicin-induced hepatotoxicity in rats: insights into the modulation of caspase, FOXOs, and heat shock protein pathways","volume":"38","author":"Kizir","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"10.1016\/j.jpet.2026.103817_bib55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3109\/0886022X.2014.882737","article-title":"The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity","volume":"36","author":"Taskin","year":"2014","journal-title":"Ren Fail"},{"issue":"9","key":"10.1016\/j.jpet.2026.103817_bib56","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.sjbs.2020.07.011","article-title":"Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction","volume":"27","author":"Afsar","year":"2020","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"10.1016\/j.jpet.2026.103817_bib57","first-page":"191","article-title":"Tofogliflozin, a highly selective inhibitor of SGLT2 blocks proinflammatory and proapoptotic effects of glucose overload on proximal tubular cells partly by suppressing oxidative stress generation","volume":"48","author":"Ishibashi","year":"2016","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.jpet.2026.103817_bib58","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.3390\/ijms22116044","article-title":"Sodium glucose co-transporter 2 inhibitors ameliorate endothelium barrier dysfunction induced by cyclic stretch through inhibition of reactive oxygen species","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.103817_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1005408","article-title":"Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats","volume":"10","author":"Koizumi","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.jpet.2026.103817_bib60","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3390\/jcm12113815","article-title":"Sodium glucose cotransporter-2 inhibitor empagliflozin increases antioxidative capacity and improves renal function in diabetic rats","volume":"12","author":"Yaribeygi","year":"2023","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.jpet.2026.103817_bib61","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1007\/s00210-024-03088-6","article-title":"Empagliflozin protective effects against cisplatin-induced acute nephrotoxicity by interfering with oxidative stress and inflammation in Wistar rats","volume":"397","author":"Farrokh-Eslamlou","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5666","key":"10.1016\/j.jpet.2026.103817_bib62","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jpet.2026.103817_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jpet.2026.103817_bib64","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.freeradbiomed.2013.07.029","article-title":"Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-\u03b21 by activating the Nrf2\/ARE pathway in glomerular mesangial cells","volume":"65","author":"Huang","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"Supplement_1","key":"10.1016\/j.jpet.2026.103817_bib65","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/db20-1138-P","article-title":"1138-P: empagliflozin ameliorates kidney injury in diabetic nephropathy via SIRT1 and TXNIP","volume":"69","author":"Liang","year":"2020","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jpet.2026.103817_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/cells14070507","article-title":"Empagliflozin plays vasoprotective role in spontaneously hypertensive rats via activation of the SIRT1\/AMPK pathway","volume":"14","author":"Kloza","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jpet.2026.103817_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2017.01.007","article-title":"Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation","volume":"378","author":"Zhang","year":"2017","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.jpet.2026.103817_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13530-023-00194-5","article-title":"Zinc oxide nanoparticles regulate NF-kB expression and restrict inflammation response in doxorubicin-induced kidney injury in rats","volume":"15","author":"Elgohary","year":"2023","journal-title":"Toxicol Environ Health Sci"},{"issue":"9","key":"10.1016\/j.jpet.2026.103817_bib69","first-page":"4017","article-title":"Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-\u03baB\/TNF-\u03b1 and TGF-\u03b2\/Smad pathways","volume":"23","author":"Guo","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.jpet.2026.103817_bib70","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2010020218","article-title":"NF-kappaB in renal inflammation","volume":"21","author":"Sanz","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40360-021-00494-x","article-title":"Protective effect of alamandine on doxorubicin-induced nephrotoxicity in rats","volume":"22","author":"Soltani Hekmat","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jpet.2026.103817_bib72","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.toxrep.2019.07.010","article-title":"Renal and testicular up-regulation of pro-inflammatory chemokines (RANTES and CCL2) and cytokines (TNF-\u03b1, IL-1\u03b2, IL-6) following acute edible camphor administration is through activation of NF-kB in rats","volume":"6","author":"Somade","year":"2019","journal-title":"Toxicol Rep"},{"issue":"2","key":"10.1016\/j.jpet.2026.103817_bib73","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI68101","article-title":"Positive feedback between NF-\u03baB and TNF-\u03b1 promotes leukemia-initiating cell capacity","volume":"124","author":"Kagoya","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jpet.2026.103817_bib74","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.jpet.2026.103817_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.12659\/MSMBR.901909","article-title":"Sirtuin1 (SIRT1) regulates tumor necrosis factor-alpha (TNF-\u03b1-induced) aquaporin-2 (AQP2) expression in renal medullary collecting duct cells through inhibiting the NF-\u03baB pathway","volume":"22","author":"Lin","year":"2016","journal-title":"Med Sci Monit Basic Res"},{"issue":"5","key":"10.1016\/j.jpet.2026.103817_bib76","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/aps.2011.189","article-title":"Sirt1 overexpression protects murine osteoblasts against TNF-\u03b1-induced injury in vitro by suppressing the NF-\u03baB signaling pathway","volume":"33","author":"Huang","year":"2012","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"10.1016\/j.jpet.2026.103817_bib77","doi-asserted-by":"crossref","first-page":"10125","DOI":"10.1007\/s00210-025-03808-6","article-title":"Febuxostat protects from Doxorubicin induced hepatotoxicity in rats via regulation of NF-\u03baB p65\/NLRP3 inflammasome and SIRT-1\/AMPK pathways","volume":"398","author":"El-Dessouki","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103817_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/ph18020248","article-title":"Withania somnifera ameliorates doxorubicin-induced nephrotoxicity and potentiates its therapeutic efficacy targeting SIRT1\/Nrf2, oxidative stress, inflammation, and apoptosis","volume":"18","author":"Mohmmed Hegab","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-020-00732-4","article-title":"Empagliflozin suppresses inflammation and protects against acute septic renal injury","volume":"29","author":"Maayah","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jpet.2026.103817_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112406","article-title":"Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats","volume":"155","author":"Osman","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"10.1016\/j.jpet.2026.103817_bib81","first-page":"1201","article-title":"Protective and therapeutic effects of empagliflozin in nephrotoxicity induced by 5-Fluorouracil in rats: role of caspase-3, inflammation and oxidative stress","volume":"14","author":"Elbadr","year":"2024","journal-title":"J Adv Vet Res"},{"key":"10.1016\/j.jpet.2026.103817_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib83","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13098-024-01325-9","article-title":"Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus","volume":"16","author":"Zhang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jpet.2026.103817_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.879522","article-title":"Cell-target-specific anti-inflammatory effect of empagliflozin: in vitro evidence in human cardiomyocytes","volume":"9","author":"Giannattasio","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jpet.2026.103817_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111147","article-title":"Phosphocreatine attenuates doxorubicin-induced nephrotoxicity through inhibition of apoptosis, and restore mitochondrial function via activation of Nrf2 and PGC-1\u03b1 pathways","volume":"400","author":"Qaed","year":"2024","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jpet.2026.103817_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109494","article-title":"Empagliflozin mitigates methotrexate-induced hepatotoxicity: targeting ASK-1\/JNK\/Caspase-3 pathway","volume":"114","author":"El-Kashef","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib87","article-title":"Empagliflozin protects against renal ischemia\/reperfusion injury in mice","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jpet.2026.103817_bib88","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/antiox13060671","article-title":"Empagliflozin alleviates carfilzomib-induced cardiotoxicity in mice by modulating oxidative stress, inflammatory response, endoplasmic reticulum stress, and autophagy","volume":"13","author":"George","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.jpet.2026.103817_bib89","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1152\/japplphysiol.00862.2016","article-title":"Involvement of glycogen synthase kinase-3\u03b2 in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats","volume":"122","author":"Yang","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jpet.2026.103817_bib90","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2014.10.509","article-title":"Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3\u03b2","volume":"81","author":"Liu","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.103817_bib91","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1440-1681.13638","article-title":"Dapagliflozin attenuates high glucose-induced endothelial cell apoptosis and inflammation through AMPK\/SIRT1 activation","volume":"49","author":"Faridvand","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib92","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13346-024-01648-0","article-title":"A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer","volume":"15","author":"Bisht","year":"2025","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib93","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12672-023-00719-x","article-title":"Empagliflozin: a potential anticancer drug","volume":"14","author":"Wu","year":"2023","journal-title":"Discov Oncol"},{"key":"10.1016\/j.jpet.2026.103817_bib94","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2020.09.005","article-title":"An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells","volume":"495","author":"Xie","year":"2020","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.jpet.2026.103817_bib95","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acsptsci.0c00144","article-title":"Empagliflozin and doxorubicin synergistically inhibit the survival of triple-negative breast cancer cells via interfering with the mTOR pathway and inhibition of calmodulin: in vitro and molecular docking studies","volume":"3","author":"Eliaa","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jpet.2026.103817_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112455","article-title":"Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: emerging approach for new application","volume":"145","author":"Abdelhamid","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2026.103817_bib97","first-page":"52","article-title":"An in-vitro and in silico anticancer study of FDA approved antidiabetic drugs glimepiride and empagliflozin","volume":"10","author":"Faridi","year":"2020","journal-title":"Int J Life Sci Pharma Res"},{"key":"10.1016\/j.jpet.2026.103817_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175565","article-title":"Empagliflozin mediated miR-128-3p upregulation promotes differentiation of hypoxic cancer stem-like cells in breast cancer","volume":"943","author":"Nalla","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2026.103817_bib99","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1007\/s00210-025-04132-9","article-title":"Effects of empagliflozin and its combination with docetaxel on LNCaP and DU-145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis","volume":"398","author":"Cumao\u011flu","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.103817_bib100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/cancers17030466","article-title":"Exploring the role of SGLT2 inhibitors in cancer: mechanisms of action and therapeutic opportunities","volume":"17","author":"Pandey","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.jpet.2026.103817_bib101","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/ijms20102519","article-title":"Adiponectin, obesity, and cancer: clash of the Bigwigs in health and disease","volume":"20","author":"Parida","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12933-021-01410-7","article-title":"Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure","volume":"20","author":"Pietschner","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jpet.2026.103817_bib103","first-page":"253","article-title":"Metabolomics insights into the benefits of SGLT2 inhibitors in type 2 diabetes","volume":"17","author":"Kyriakidou","year":"2025","journal-title":"Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103817_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-023-02094-x","article-title":"The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator","volume":"23","author":"Thirumathyam","year":"2024","journal-title":"Cardiovasc Diabetol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:50:10Z","timestamp":1794563410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022356526000157"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103817","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin mitigates doxorubicin-induced nephrotoxicity by modulating sirtuin 1, nuclear factor-\u03baB\/tumor necrosis factor-\u03b1, and cleaved caspase-3 pathways without compromising its cytotoxic efficacy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103817"}}